Vivos Therapeutics, Inc. - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
VVOS Nasdaq 3840 www.vivos.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Vivos Therapeutics, Inc.

Vivos Therapeutics Announces Exercise of Warrants for $4.64 Million Gross Proceeds - Jan 16th, 2026 6:00 am
Vivos Therapeutics (VVOS) Upgraded to Buy: Here's What You Should Know - Jan 5th, 2026 10:00 am
Vivos Therapeutics Announces Grand Opening of Affiliated Sleep Center Near Detroit, Michigan - Dec 16th, 2025 6:45 am
Vivos Therapeutics to Participate in Online Fireside Chat with Water Tower Research on December 16, 2025, at 11 am EST - Dec 15th, 2025 3:30 pm
Vivos Therapeutics Inc (VVOS) Q3 2025 Earnings Call Highlights: Revenue Surge Amid Strategic ... - Nov 26th, 2025 6:01 pm
Vivos Therapeutics Reports Significant Revenue Growth During the Third Quarter 2025 - Nov 19th, 2025 2:20 pm
Vivos Therapeutics Schedules Release of Third Quarter 2025 Financial Results and Conference Call - Nov 19th, 2025 6:30 am
ARS Pharmaceuticals, Inc. (SPRY) Reports Q3 Loss, Beats Revenue Estimates - Nov 10th, 2025 5:05 am
Aclaris Therapeutics (ACRS) Reports Q3 Loss, Tops Revenue Estimates - Nov 6th, 2025 6:05 am
Vivos Therapeutics Releases Additional Clinical Data Showing Marked Improvement in Pediatric ADHD from Use of Vivos DNA Device - Sep 30th, 2025 6:30 am
Vivos Therapeutics Announces Landmark Clinical Trial Results in Pediatric Obstructive Sleep Apnea Treatment - Sep 17th, 2025 6:30 am
Sleep Apnea Economic Burden in U.S. Exceeds $150B Annually--Vivos' Novel Solution Can Help - Sep 2nd, 2025 6:16 am
Vivos Therapeutics Inc (VVOS) Q2 2025 Earnings Call Highlights: Navigating Revenue Challenges ... - Aug 20th, 2025 1:06 am
Vivos Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update - Aug 19th, 2025 2:20 pm
Vivos Therapeutics Schedules Release of Second Quarter 2025 Financial Results and Conference Call - Aug 19th, 2025 6:30 am
Lyra Therapeutics, Inc. (LYRA) Reports Q2 Loss, Beats Revenue Estimates - Aug 12th, 2025 3:15 pm
Vivos Calls Out Medical Blind Spot: OSA's Overlooked Dangerous Symptoms - Aug 7th, 2025 6:03 am
Vivos Therapeutics Adds to Management Team to Support Expansion and Growth - Jul 30th, 2025 6:45 am
Ionis Pharmaceuticals (IONS) Q2 Earnings and Revenues Beat Estimates - Jul 30th, 2025 6:10 am
Ignored and Undiagnosed: Sleep Apnea Threatens Women's Cognitive Health - Jul 22nd, 2025 6:42 am